(SRHR) Elevation Series Trust - Ratings and Ratios
Exchange: NYSE ARCA •
Country: USA •
Currency: USD •
Type: Etf •
ISIN: US2103223010
Real Estate, Trusts, Stocks, Options
Description: SRHR Elevation Series Trust
from quarterly Tax Provision
SRHR ETF Overview
| Market Cap in USD | 49m |
| Category | Real Estate |
| TER | 0.75% |
| IPO / Inception | 2023-11-01 |
SRHR ETF Ratings
| Growth Rating | 4.80 |
| Fundamental | - |
| Dividend Rating | 48.0 |
| Rel. Strength | -4.11 |
| Analysts | - |
| Fair Price Momentum | 57.62 USD |
| Fair Price DCF | - |
SRHR Dividends
| Dividend Yield 12m | 6.65% |
| Yield on Cost 5y | 7.93% |
| Annual Growth 5y | 166.13% |
| Payout Consistency | 66.7% |
| Payout Ratio | % |
SRHR Growth Ratios
| Growth Correlation 3m | 3.4% |
| Growth Correlation 12m | -76.8% |
| Growth Correlation 5y | 51% |
| CAGR 5y | 9.62% |
| CAGR/Max DD 5y | 0.52 |
| Sharpe Ratio 12m | 0.59 |
| Alpha | -16.59 |
| Beta | 0.584 |
| Volatility | 14.56% |
| Current Volume | 0.1k |
| Average Volume 20d | 0.1k |
| Stop Loss | 52.2 (-3.1%) |
| Signal | 0.19 |
What is the price of SRHR shares?
As of August 15, 2025, the stock is trading at USD 53.88 with a total of 100 shares traded.
Over the past week, the price has changed by -0.05%, over one month by -2.31%, over three months by +0.89% and over the past year by -3.11%.
Over the past week, the price has changed by -0.05%, over one month by -2.31%, over three months by +0.89% and over the past year by -3.11%.
Is Elevation Series Trust a good stock to buy?
Neither. Based on ValueRay´s Analyses, Elevation Series Trust is currently (August 2025)
neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 4.80 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SRHR is around 57.62 USD . This means that SRHR is currently overvalued and has a potential downside of 6.94%.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SRHR is around 57.62 USD . This means that SRHR is currently overvalued and has a potential downside of 6.94%.
Is SRHR a buy, sell or hold?
Elevation Series Trust has no consensus analysts rating.
What are the forecasts/targets for the SRHR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 64.1 | 18.9% |
Last update: 2025-08-15 15:06
SRHR Fundamental Data Overview
Market Cap USD = 48.9m (48.9m USD * 1.0 USD.USD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 0.0
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 48.9m USD (48.9m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 48.9m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 48.9m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(48.9m)/V(0.0) * Re(8.17%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 8.17% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 0.0
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 48.9m USD (48.9m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 48.9m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 48.9m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(48.9m)/V(0.0) * Re(8.17%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 8.17% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for SRHR ETF
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle